PTJ
GILD icon

Paul Tudor Jones’s Gilead Sciences GILD Stock Holding History

Paul Tudor Jones’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Sell
8,700
-23,700
-73% -$3.12M ﹤0.01% 2353
2026
Q1 		$4.52M Buy
32,400
+23,700
+272% +$3.32M 0.01% 1231
2025
Q4 		$1.07M Sell
8,700
-29,000
-77% -$3.52M ﹤0.01% 2231
2025
Q3 		$4.18M Buy
37,700
+29,100
+338% +$3.31M 0.01% 1301
2025
Q2 		$953K Buy
+8,600
New +$915K ﹤0.01% 2169
2024
Q2 		– Sell
-27,100
Closed -$1.99M – 2498
2024
Q1 		$1.99M Buy
27,100
+11,000
+68% +$846K 0.01% 1030
2023
Q4 		$1.3M Buy
+16,100
New +$1.25M 0.01% 1323
2014
Q2 		– Sell
-75,000
Closed -$5.32M – 1221
2014
Q1 		$5.32M Buy
+75,000
New +$5.88M 0.23% 75

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paul Tudor Jones's GILD Position: Q2 2026 in Review

Paul Tudor Jones increased its Gilead Sciences (GILD) stake by 28% in Q2 2026, buying an estimated $2.18M and bringing the position to 74,896 shares worth $9.46M. The position accounts for 0.01% of the portfolio, ranked #857.

Paul Tudor Jones first reported a position in GILD in Q2 2013 and has held it in 40 quarters since. The position peaked at $35.7M in Q2 2024. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Paul Tudor Jones held 74,896 shares of Gilead Sciences worth $9.46M as of Q2 2026.
  • Paul Tudor Jones bought 16,527 Gilead Sciences shares in Q2 2026, an estimated $2.18M.
  • Gilead Sciences made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #857 holding.
  • Paul Tudor Jones first reported a position in Gilead Sciences in Q2 2013 and has held it in 40 quarters since.
  • Paul Tudor Jones's Gilead Sciences position peaked at $35.7M in Q2 2024.
  • 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.